Coloplast introduced New Catheter, SpeediCath Flex Set with Triple Action Coating Technology, for people living with bladder and urinary problems to enhance their catheterization procedures in a variety of ways, and to lower the risk of urethral injury and urinary tract infections (UTIs).
Boston Scientific Corporation received approval from the U.S. Food and Drug Administration (FDA) for its POLARx Cryoablation System which uses the POLARx FIT Cryoablation Balloon Catheter, to treat patients with paroxysmal atrial fibrillation (AF).
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5184
Published Date: Aug 23, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing prevalence of chronic kidney disorders and the rising popularity of minimally invasive procedures are the major factors driving the growth of the market.
The market size of Urethral Dilators is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Enfucell Oy, STMicroelectronics International N.V., LG Chem, Ltd., Cymbet Corporation, Imprint Energy Inc, Jenax Inc., Samsung SDI Co., Ltd., Excellatron Solid State, LLC, and others.
The disposable segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.